Flenodic Im 25 mg/ml Injection

Flenodic Im 25 mg/ml Injection

S3
PDF Leaflet Revision Date: 06 November 2025


Clinical Summary

Quick overview from the medicine insert

Indication

Initial therapy for inflammatory and degenerative rheumatic disease.

Dosage (summary)

Adults: 75 mg once daily; severe cases: 75 mg twice daily.

Onset of Action / Duration

Onset: 30 mins, Duration: 6-8 hours

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation; may impair fertility.

Key Drug Interactions

  • Methotrexate
  • Anticoagulants
  • Lithium
  • Digoxin

Contraindications

  • Hypersensitivity to diclofenac
  • Gastric or intestinal ulcer
  • Severe renal impairment
  • Active bleeding disorders

Common side effects

  • Gastrointestinal bleeding
  • Nausea
  • Headache
  • Dizziness

Counselling Points

  • Use the lowest effective dose for the shortest duration
  • Report any unusual abdominal symptoms
  • Avoid use with other NSAIDs

Serious warnings

  • Risk of gastrointestinal perforation
  • Serious skin reactions
  • Cardiovascular risks

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Flenodic Im 25 mg/ml Injection
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW